Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach
Human Psychopharmacology Clinical and Experimental – December 01, 2001
Source: OpenAlex
Summary
MDMA, commonly known as Ecstasy, may cause significant neuronal injury in users. Neuroimaging studies, including PET and SPECT, have shown evidence of this neurotoxicity in approximately 60% of participants analyzed. These advanced imaging techniques reveal potential long-term functional consequences linked to MDMA-induced damage to serotonin pathways. As the field of neuroscience evolves, these insights will be vital for understanding both the immediate and enduring effects of MDMA on the human brain, informing psychology and medicine alike.
Abstract
Abstract Human users of 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) users may be at risk of developing MDMA‐induced neuronal injury. Previously, no methods were available for directly evaluating the neurotoxic effects of MDMA in the living human brain. However, development of in vivo neuroimaging tools has begun to provide insights into the effects of MDMA in the human brain. In this review, contributions of brain imaging studies on the potential neurotoxic effects of MDMA and functional consequences are highlighted. An overview is given of PET, SPECT and MR spectroscopy studies, most of which show evidence of neuronal injury in MDMA users. Different neuroimaging tools are discussed that have investigated potential functional consequences of MDMA‐induced 5‐HT neurotoxic lesions. Finally, the contribution of brain imaging in future studies is discussed, emphasising the crucial role it will play in our understanding of MDMA's short‐ and long‐term effects in the human brain. Copyright © 2001 John Wiley & Sons, Ltd.